Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. In Part 2 of this series on Research Champions referring physicians spoke for themselves through primary research conducted by BBK Worldwide. Today, we look at best practices that lead to referring physician programs that generate compelling results.
Part 1 in this series of blogs on the role of referring physicians in clinical research chronicled the factors that have led to study sponsors’ lack of confidence in physician referrals as an effective patient recruitment strategy. This installment gives voice to the referring physicians themselves by sharing results of primary research conducted by BBK Worldwide.
Long ago, in a land far away, principal investigators were expected to “accrue study subjects” using their network of physician colleagues. Enrolling subjects from one’s patient panel was discouraged as therapeutic misconception might impugn study results. As a result, acceptable enrollment might run from 36 to 60 months or more.
Investigators would commonly send a “Dear Doctor” letter to others within their hospital or to their personal connections. Rarely did these letters produce effective results. Over time, referring physician programs altogether lost value and credibility due to a few commonly held beliefs:
Today’s blog is brought to you by Kris Sarajian at BioPharm Clinical. Last week, BioPharm Clinical teamed up with BBK Worldwide, a valued partner for nearly a decade, to deliver a joint webinar on how new types of patient data are helping clinical operations teams improve research study feasibility and investigator selection in order to maximize patient recruitment (In case you missed it, you can get the slides and watch a recording on the BioPharm website).
“Principal Investigators have vast amounts of time, money, and resources to find large numbers of potentially eligible patients to participate in their clinical research study,” said no one… ever. As clinical studies have become increasingly more competitive, more time-consuming, and more stringent in terms of eligibility criteria, it’s never been more important to provide PIs with easy-to-use tools that can inform, engage, and motivate.
As if this summer wasn’t hot enough, we’re turning up the heat a little more by introducing exciting products and services during our shop.BBKWorldwide.com Summer Sale. Each Monday we’ll be showcasing one product and delving a little deeper into how it can benefit the entire clinical research community. So, as we begin the month of August, here is a sneak peek at some of the products we’ll be showcasing.
Co-Founder of BBK Worldwide Joan F. Bachenheimer wrote in a recent blog, “When options are limited, the medical community has an obligation to convey to patients the clinical trial options available to their patients.” Physicians play a crucial role in this and therefore it is important to foster relationships with them. Here’s an example of how.
Having played a significant role in recruiting patients to clinical trials for more years than I care to admit, I've learned a thing or two about how the medical community relates to the option of clinical trials for their patients. Here it goes: